# Cardinal Health, Inc – FDA Inspection, Feb 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/cardinal-health-inc/0021303a-8b41-48f4-b287-2593fa23a601
Source feed: FDA_Inspections

> FDA inspection 1304424 of Cardinal Health, Inc, February 21, 2026. 2 citations under 21 CFR part 212. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304424
- Company Name: Cardinal Health, Inc
- Inspection Date: 2026-02-21
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 977922 - 2016-05-26](https://www.keypedia.com/records/fda_inspections/cardinal-health-inc/7c2064b4-0c31-4a2b-b58c-589dedfcccb9)
- FDA Inspection 892549 - 2014-08-18
- FDA Inspection 799530 - 2012-09-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/claudia-m-perez-kasmarski/ee989ba2-eb7a-47ae-8be5-7a28f748343b)

Company: https://www.keypedia.com/companies/cardinal-health-inc/2d5c7072-192f-4c99-b62d-10cac97733a0

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9